scholarly journals Identification of Klebsiella pneumoniae carbapenemase in Sweden

2007 ◽  
Vol 12 (51) ◽  
Author(s):  
K Tegmark-Wisell ◽  
S Hæggman ◽  
L Gezelius ◽  
O Thompson ◽  
I Gustafsson ◽  
...  
Keyword(s):  
Intensive Care ◽  
Tract Infection ◽  
Klebsiella Pneumoniae ◽  
Obstructive Lung Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
Intensive Care Treatment ◽  
Klebsiella Pneumoniae Carbapenemase ◽  
History Of

A Klebsiella pneumoniae expressing carbapenemase type 2 (KPC-2) enzyme has been identified in Sweden. The patient, who had a history of chronic obstructive lung disease, developed a respiratory tract infection while on holiday in Greece. After initial intensive care treatment in Greece, the patient was transferred to Sweden.

Adverse Dermatologic Reaction to Transdermal Nitroglycerin

1984 ◽  
Vol 18 (1) ◽  
pp. 69-70 ◽  
Author(s):  
Peter W. Letendre ◽  
Charles Barr ◽  
Kim Wilkens
Keyword(s):  
Transdermal Delivery ◽  
Obstructive Lung Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
Adult Onset ◽  
Ulcer Disease ◽  
History Of ◽  
Adult Onset Diabetes ◽  
Transdermal Delivery System

The incidence of adverse effects from transdermal nitroglycerin systems is reported to be very low. A cutaneous reaction from Transderm-Nitro is described. The patient in this case was a 63-year-old male with a history of chronic obstructive lung disease, adult onset diabetes mellitus, peptic ulcer disease, congestive heart failure, and angina pectoris. Seven weeks after having used a Transderm-Nitro-5 patch daily, the patient was found to have two macular erythematous areas on his chest that corresponded to the exact sites of the nitroglycerin patch. Follow-up with the same patient, using a placebo Transderm-Nitro, elicited a reaction similar in appearance. The exact causative agent is unknown, but it is believed to be from the transdermal delivery system and not the nitroglycerin.

“Natural History” of Pulmonary Hypertension in a Series of 131 Patients with Chronic Obstructive Lung Disease

2001 ◽  
Vol 164 (2) ◽  
pp. 219-224 ◽  
Author(s):  
ROMAIN KESSLER ◽  
MICHÈLE FALLER ◽  
EMMANUEL WEITZENBLUM ◽  
ARI CHAOUAT ◽  
ATTILA AYKUT ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Natural History ◽  
Lung Disease ◽  
Obstructive Lung Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
History Of

scholarly journals Virus infections and the natural history of chronic obstructive lung disease

Lung ◽  
1970 ◽  
Vol 142 (1) ◽  
pp. 1-6
Author(s):  
W. Klaer ◽  
Bergith Reinert ◽  
F. Trendelenburg ◽  
R. Wigand
Keyword(s):  
Natural History ◽  
Lung Disease ◽  
Obstructive Lung Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
Virus Infections ◽  
History Of

scholarly journals Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID‐19

Allergy ◽  
2020 ◽  
Vol 75 (10) ◽  
pp. 2703-2704 ◽  
Author(s):  
Sergey Avdeev ◽  
Sergey Moiseev ◽  
Michail Brovko ◽  
Andrey Yavorovskiy ◽  
Karina Umbetova ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Lung Disease ◽  
Bronchial Asthma ◽  
Obstructive Lung Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
Low Prevalence

A CORRELATIVE STUDY OF ELECTROCARDIOGRAPHY, ECHOCRDIOGRAPHY AND HEMATOLOGICAL FINDINGS IN CHRONIC OBSTRUCTIVE LUNG DISEASE

2021 ◽  
pp. 3-3
Author(s):  
B.Pani Kumar ◽  
Arshida Arshida ◽  
Sravan kumar
Keyword(s):  
Cause Of Death ◽  
Obstructive Lung Disease ◽  
Respiratory Symptoms ◽  
Chronic Obstructive Lung Disease ◽  
Airflow Limitation ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Mortality And Morbidity ◽  
The Third ◽  
History Of

INTRODUCTION Chronic obstructive pulmonary disease is one of the commonest cause of mortality and morbidity in our country. It is dened as “a common preventable and treatable disease characterised by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.” COPD is currently fourth leading cause of death in the world1 but is projected to be the third leading cause of death by 2020. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets that could alter the natural history of this devastating disorder.

Sign in / Sign up

Export Citation Format

Share Document